NxStage Medical, Inc. 4
4 · NxStage Medical, Inc. · Filed May 27, 2016
Insider Transaction Report
Form 4
Giannini Daniel A
Director
Transactions
- Tax Payment
Common Stock
2016-05-25$18.81/sh−13,807$259,710→ 63,973 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-05-25−14,000→ 0 totalExercise: $18.55From: 2011-05-26Exp: 2016-05-25→ Common Stock (14,000 underlying) - Exercise/Conversion
Common Stock
2016-05-25$18.55/sh+14,000$259,700→ 77,780 total - Award
Stock Option (Right to Buy)
2016-05-26+15,854→ 15,854 totalExercise: $18.32From: 2016-06-26Exp: 2023-05-25→ Common Stock (15,854 underlying)
Footnotes (1)
- [F1]The stock option becomes exercisable in 12 equal monthly installments beginning June 26, 2016.